139 related articles for article (PubMed ID: 3459399)
1. [The comparative study of biological behavior between primary lesion and metastatic lymph node of gastric cancer--immunohistochemical study of CEA and CA 19-9].
Takahashi Y; Minami S; Mai M
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2233-4. PubMed ID: 3459399
[No Abstract] [Full Text] [Related]
2. [Immunohistochemical study of the localization and distributional patterns of CA 19-9 and CEA in primary and metastatic nodal lesions of gastrointestinal cancer].
Deguchi H; Tabuchi Y; Saitoh Y
Gan No Rinsho; 1990 Jul; 36(8):890-4. PubMed ID: 1694901
[TBL] [Abstract][Full Text] [Related]
3. [Assay of serum carbohydrate antigen (CA) 19-9 in the diagnosis of gastric cancer].
Nishida K; Yamamoto T; Yoshioka K; Iida M; Miyagawa H; Yoshikawa T; Sugino S; Kondo M
Gan To Kagaku Ryoho; 1986 Jan; 13(1):101-8. PubMed ID: 3455804
[TBL] [Abstract][Full Text] [Related]
4. [Carcinoembryonic antigen, Ca 19-9 and Ca 125 antigen levels in the sera of patients with cancer of the stomach].
Bukowski J; Góźdź S; Słuszniak J; Słuszniak A; Korejba W; Zieliński A; Banasińska E
Pol Tyg Lek; 1988 Feb; 43(5):136-9. PubMed ID: 3165528
[No Abstract] [Full Text] [Related]
5. [Improving the diagnostic efficacy of carcinoembryonic antigen (CEA) in gastric cancer by the simultaneous administration of Ca 72.4].
Sagredo E; Soriano A; Vivanco FJ; Ruibal A
Rev Clin Esp; 1989 Apr; 184(6):336-7. PubMed ID: 2756226
[No Abstract] [Full Text] [Related]
6. [An autopsy case of a gastric cancer associated with elevated AFP, CEA and CA19-9].
Nakamura Y; Hozumi T; Ohkita M; Masuda S; Maeda M; Okada K; Chinzei T; Yamashiro K; Harui M; Hosokawa I
Gan No Rinsho; 1988 Feb; 34(2):213-8. PubMed ID: 2450214
[TBL] [Abstract][Full Text] [Related]
7. [The relation between serum carcinoembryonic antigens (CEA) and response to chemotherapy in patients with advanced gastric cancer].
Saito D; Yoshida S; Hijikata A; Tajiri H; Yamaguchi H; Yoshimori M; Ohkura H; Okazaki N; Yoshida T; Yoshino M
Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):948-57. PubMed ID: 3480325
[No Abstract] [Full Text] [Related]
8. [Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9].
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Med Klin (Munich); 1986 Mar; 81(6):199-201. PubMed ID: 3466003
[No Abstract] [Full Text] [Related]
9. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
[TBL] [Abstract][Full Text] [Related]
10. Correlation between positive CA 72-4 serum levels and lymph node involvement in patients with gastric carcinoma.
Guadagni F; Roselli M; Cosimelli M; Ferroni P; Spila A; Casaldi V; Cavaliere F; Carlini M; Garofalo A; Rinaldi G
Anticancer Res; 1993; 13(6B):2409-13. PubMed ID: 8135475
[TBL] [Abstract][Full Text] [Related]
11. [Preoperative determination of CEA and GICA in gastric neoplasms].
Sanlorenzo M; Caldarola F; Vigezzi P; Rocca N; Pecchio F
Minerva Med; 1989 Mar; 80(3):255-9. PubMed ID: 2717045
[TBL] [Abstract][Full Text] [Related]
12. [Histopathological and immunohistochemical studies on the elevation mechanism of cancer associated antigens, CEA and CA19-9, in gastric cancer patients].
Tabuchi Y; Deguchi H; Saitoh Y
Nihon Geka Gakkai Zasshi; 1988 Aug; 89(8):1181-91. PubMed ID: 3185486
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of a new tumor marker, CA 15-3, in breast cancer; a comparative study with CEA].
Komuro K; Watanabe K; Ishida T; Sakurai M; Amano R; Hagiwara H; Hara Y; Hanzawa T; Itsubo K
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3145-9. PubMed ID: 3465273
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of CA72-4 as a tumor marker in patients with gastric cancer].
Ubukata H; Katano M; Motohashi G; Kasuga T; Takemura A; Tabuchi T; Tabuchi T
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1821-4. PubMed ID: 14619529
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for liver metastases after curative surgical procedures for gastric cancer: a prospective study of 208 patients treated with surgical resection.
Marrelli D; Roviello F; De Stefano A; Fotia G; Giliberto C; Garosi L; Pinto E
J Am Coll Surg; 2004 Jan; 198(1):51-8. PubMed ID: 14698311
[TBL] [Abstract][Full Text] [Related]
16. Serum CA 19-9, SLX, STN and CEA levels of the peripheral and the draining venous blood in gastric cancer.
Imada T; Rino Y; Takahashi M; Hatori S; Shiozawa M; Amano T; Kondo J
Hepatogastroenterology; 1999; 46(27):2086-90. PubMed ID: 10430402
[TBL] [Abstract][Full Text] [Related]
17. [Value of CA 19-9 in tumor after-care in stomach and colorectal cancer].
Safi F; Rappenecker B; Roscher R; Beger HG
Med Klin (Munich); 1986 Jan; 81(1):12-4. PubMed ID: 3466002
[No Abstract] [Full Text] [Related]
18. [Clinical utility of tumor markers in gastric and colon cancer].
Ogawa K; Naritaka Y; Koyama N; Ohtani Y; Kawata H; Yagawa H; Kajiwara T; Sakakibara N
Gan No Rinsho; 1985 May; 31(6 Suppl):638-47. PubMed ID: 3861884
[TBL] [Abstract][Full Text] [Related]
19. Significance of proliferating cell nuclear antigen (PCNA) expression in gastric cancer in relation to lymph node metastasis.
Isozaki H; Okajima K; Ichinona T; Fujii K; Nomura E; Izumi N; Takeda Y
J Surg Oncol; 1996 Feb; 61(2):106-10. PubMed ID: 8606541
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of sialyl Tn, sialyl Lewis a, sialyl Lewis a-b-, and sialyl Lewis x in primary tumor and metastatic lymph nodes in human gastric cancer.
Ikeda Y; Mori M; Kajiyama K; Haraguchi Y; Sasaki O; Sugimachi K
J Surg Oncol; 1996 Jul; 62(3):171-6. PubMed ID: 8667623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
